Media

News

[Merger Market] Oncocross welcomes pre-IPO investors for AI drug development; mandates NH I&S for KOSDAQ listing
관리자
Date : 2020.09.04

 

mm 기사.JPG

 

mm 기사_1.JPG

 

mm 기사_2.JPG